Ventilator-associated pneumonia: gearing towards shorter-course therapy

Title

Ventilator-associated pneumonia: gearing towards shorter-course therapy

Creator

Chua T D; File T M

Publisher

Current Opinion in Infectious Diseases

Date

2006
2006-04

Description

Purpose of review The studies that are reviewed in this article have all concluded that a shorter duration of antibiotic therapy (7-8 days) may be adequate in the treatment of the majority of patients with ventilator-associated pneumonia, and does not confer an increased incidence of mortality. Recent findings Ventilator-associated pneumonia has traditionally been treated with at least 2 weeks of antimicrobial therapy. With the increasing emergence of multi-drug-resistant pathogens, however, efforts have been directed at minimizing the duration of therapy. Several studies have emerged over the last few years aiming to shorten the duration of antimicrobial therapy for ventilator-associated pneumonia. Summary The minimum effective duration of antibiotic therapy, however, remains unclear. Further studies geared towards determining this are needed.

Subject

pneumonia; Infectious Diseases; trial; infection; antibiotic-therapy; resolution; Antimicrobial therapy; duration of therapy; pseudomonas-aeruginosa; ventilator-associated

Identifier

n/a

Format

Journal Article or Conference Abstract Publication

URL Address

n/a

Search for Full-text

Users with a NEOMED Library login can search for full-text journal articles at the following url: https://libraryguides.neomed.edu/home

Rights

Article information provided for research and reference use only. All rights are retained by the journal listed under publisher and/or the creator(s).

Pages

185-188

Issue

2

Volume

19

Citation

Chua T D; File T M, “Ventilator-associated pneumonia: gearing towards shorter-course therapy,” NEOMED Bibliography Database, accessed February 25, 2021, https://neomed.omeka.net/items/show/8943.

Social Bookmarking